Gensciences Funding: $159M Raised, Series D (2024)

Gensciences is based in Hangzhou, China. It has raised $159M in total funding. Latest round: Series D.

Gensciences funding overview

Gensciences is based in Hangzhou, China. Gensciences has raised $159M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series D announced in May 2024. The round record for Gensciences runs through 2024; nothing later has been disclosed. Investors on record include IDG Capital, HT Capital, China Life Healthcare Capital. 3 distinct backers are named across the disclosed rounds.

Gensciences at a glance

Total raised
$159M
Latest round
Series D
Latest round date
May 2024
Headquarters
Hangzhou, China
Notable investors
IDG Capital, HT Capital, China Life Healthcare Capital

Frequently asked about Gensciences funding

How much has Gensciences raised?
Gensciences has raised $159M in total disclosed funding across the rounds on record.
Who has invested in Gensciences?
IDG Capital, HT Capital, China Life Healthcare Capital are named among the investors backing Gensciences.
What was the latest Gensciences funding round?
The most recent disclosed round is a Series D, announced in May 2024.
Where is Gensciences based?
Gensciences is based in Hangzhou, China.
When did Gensciences last raise?
The last disclosed Gensciences round closed in May 2024 at Series D.

Every Gensciences figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Hangzhou at a similar stage.

Companies related to Gensciences (35)

Browse related funding lists (4)

Company funding database · Investor directory · Founder database · Mega-rounds 2026